About Us | US COPD Coalition

The mission of the U.S. COPD Coalition is to improve awareness and care of patients with COPD while supporting the search for a cure.

The USCC has several goals:

Educate key audiences and lawmakers on the importance of improving prevention and detection of COPD, the need for additional research aimed at better understanding COPD and the need for new approaches to prevention and treatment;
Promote COPD awareness and education through its role as a resource for programs and constituents of its member organizations and partners;
Provide a strong and unified advocacy voice to support policies and regulations important to the COPD Community;
Aspire to reach undiagnosed patients with information about COPD and improve quality of life for all those impacted by COPD.

Congressional COPD Caucusplus

The Coalition serves as a primary liaison with the Congressional COPD Caucus. State and local organizations are able to use the Coalition as a public policy hub, sharing their advocacy ideas and needs in order to present them in an efficient manner.

Visit the Caucus & Advocacy Page

Collaboration with Membersplus

The USCC actively explores all avenues for fostering collaboration in the COPD community and supporting meaningful COPD advocacy activities. The Coalition’s core role as a network for information sharing and collective advocacy voice is supplemented by several programs and resources designed to help all member organizations achieve their COPD related goals. Included in these programs are patient screenings, educational programs, workshops, and other events. The U.S. COPD Coalition is also working with the National Heart, Lung, and Blood Institute in the promotion of its national campaign, “COPD Learn More Breathe Better” to increase awareness and understanding of COPD and its risk factors and to underscore the benefits of early detection and treatment in slowing the disease and improving the quality of life.

Visit the Members & Board Page

Business Meetingsplus

Each year the USCC convenes two meetings in conjunction with one of its member organization’s national conferences. The business meetings serve as a forum for member organizations and partners from the COPD community to share, discuss and improve coordination of activities. The meetings are also webcasted to ensure all members are able to participate and to increase the scope of participation to include additional community partners. Business meetings include topics specific to the governance of the Coalition but also include public policy updates, the latest news in research, awareness and education programs and a dedicated open forum for members to provide updates on key activities.

Visit the News & Events Page

State Coalitionsplus

The USCC has partnered with many of the State COPD Coalitions to support and promote their activities through its communication channels. As states begin their efforts in COPD, usually by convening a state summit, the Coalition has been able to provide a supporting role in the organization and content of these gatherings. The Coalition interfaced with its member organizations to provide state level chapter representation at the Summits as well as used its communication channels to promote the summit to potential participants. Additionally, Coalition representation attended two summits in person and has attended several post-summit State COPD Coalition events. State coalitions that do not have a web presence are able to build a dedicated web page on the USCC’s website free of charge. This web presence allows state coalitions to house their membership information, action plans and more, giving them visibility and an easy way to showcase their work.

Visit the State Coalitions Page

News & Events

NIH Study Finds Probiotic Bacillus Effective Against Staphylococcus Bacteria

USCC Joins Other Advocacy Groups in Letter to CMS

Congressman Chris Stewart to Co-Chair Congressional COPD Caucus

CPAP Mask Cushion Recalled Due to Possible Air Leaks

Second-Hand Smoke Exposure as Child Raises Risk of Death from COPD as Adult

Generic EpiPen Approved by FDA